GENEVA, Sept. 7 -- REGENXBIO, INC. filed a patent application (US2026/017151) for “RECOMBINANT ADENO-ASSOCIATED VIRUSES AND USES THEREOF”. With publication no. WO/2026/183520, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 14/005
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....